Retinoic acid and epidermal growth factor binding in retinoid-mediated invasion suppressed human lung carcinoma cells

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Lung carcinoma cell invasion is a critical factor in metastasis.
• Retinoic acid (RA) is known to modulate cell growth and differentiation.
• Epidermal growth factor (EGF) plays a role in cell proliferation and survival.

Purpose of the Study:

• To investigate how retinoic acid (RA)-induced suppression of A549 human lung carcinoma cell invasion affects cellular binding of RA and epidermal growth factor (EGF).
• To determine the relationship between RA's anti-invasive effects and the expression of cellular retinoic acid binding protein (CRABP).

Main Methods:

• A549 human lung carcinoma cells were treated with retinoic acid (RA).
• In vitro cell invasion assays were performed.
• Cellular binding of RA and 125I-EGF was measured.
• Cytosolic CRABP levels were quantified using radioligand binding assays.

Main Results:

• Retinoic acid (RA) treatment significantly suppressed the in vitro invasive ability of A549 cells.
• RA treatment led to a 2.7-fold increase in cytosolic cellular retinoic acid binding protein (CRABP) levels in treated cells compared to controls.
• The binding of 125I-EGF to cells remained similar in both RA-treated and control groups, indicating no significant effect on EGF receptor binding.

Conclusions:

• Retinoic acid (RA) inhibits lung cancer cell invasion, potentially mediated by an increase in cellular retinoic acid binding protein (CRABP).
• The anti-invasive effect of RA is specific and does not appear to involve alterations in epidermal growth factor (EGF) binding.
• CRABP upregulation is a key molecular event associated with RA's anti-invasive activity in A549 lung carcinoma cells.